Monday, March 05, 2012 6:12:26 PM
My 2 Cents Real Quick.......
Doc, quite the classy guy! Thanks for being
honest and an apology really isnt needed.
You gave an opinion on a Chart, we all watched
and listened, AND THEN.....
Its OUR job to take the information, and decide
and decipher it, to use it, or not, how we see
best.
To be upset, mad, hurt, vengeful, etc. is out of
line for anyone not getting the results he or she
wanted. You ARE NOT children here.
Lastly, apology needed or not, you stepped up, and
took the shots, and showed that you have class and
integrity by helping try and mend views, and rise
above those that would use it against you.
Kudos Bud,
VLF
Doc, quite the classy guy! Thanks for being
honest and an apology really isnt needed.
You gave an opinion on a Chart, we all watched
and listened, AND THEN.....
Its OUR job to take the information, and decide
and decipher it, to use it, or not, how we see
best.
To be upset, mad, hurt, vengeful, etc. is out of
line for anyone not getting the results he or she
wanted. You ARE NOT children here.
Lastly, apology needed or not, you stepped up, and
took the shots, and showed that you have class and
integrity by helping try and mend views, and rise
above those that would use it against you.
Kudos Bud,
VLF
Buy and Sell at your own Risk. Dont point fingers, and make excuses. After all, wasnt it you that clicked the Buy Button?
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
